Functional Outcomes Following Chemoradiotherapy for Head and Neck Cancer

Abstract

OBJECTIVE: To study functional outcomes following concurrent chemoradiotherapy of head and neck cancer.

METHODS: A retrospective chart review assessed diet, feeding tube use, and tracheotomy pretreatment and 3, 6, 12, and 24 months posttreatment.

RESULTS: Of 196 patients who underwent chemoradiotherapy between 1990 and 2002, 148 (76%) required feeding tubes immediately posttreatment; 150 (77%) required nutritional support at 3 months. By 12 months, 92% were tube-free and 83% resumed near-normal diet. Of 17 patients (9%) with tracheotomy posttreatment, 71% were decannulated by 6 months. Stage IV disease strongly predicted prolonged feeding tube use and slow recovery of diet; age ≥60 also predicted slow recovery. Primary site, gender, and radiotherapy schedule did not predict functional recovery after adjusting for stage and age.

CONCLUSION: Few patients required tracheotomy before or during chemoradiotherapy. Many patients required feeding tubes and nutritional support for several months following therapy, but most were tube-free and eating near-normal diets within 1 year. EBM rating: C.

Get full access to this article

View all access options for this article.

References

Dimery

Hong

Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95–111.

Adelstein

Tan

Lavertu

Treatment of head and neck cancer: The role of chemotherapy. Crit Rev Oncol Hematol 1996;24:97–116.

Nguyen

Sallah

Karlsson

. Combined chemotherapy and radiation therapy for head and neck malignanices: Quality of life issues. Cancer 2002;94:1131–41.

Wendt

Grabenbauer

Rodel

. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998;16:1318–24.

Lavertu

Adelstein

Saxton

. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:142–8.

Pignon

Bourhis

Domenge

. Chemotherapy added to locoregional treatment for head and neck squamouscell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949–55.

Terrell

Fisher

Wolf

. Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998;124:964–71.

McDonough

Varvares

Dunphy

. Changes in quality of life scores in a population of patients treated for squamous cell carcinoma of the head and neck. Head Neck 1996;18:487–93.

Lazarus

Logemann

Pauloski

. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996; 106:1157–66.

10.

Smith

Kotz

Beitler

. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: Initial results. Arch Otolaryngol Head Neck Surg 2000;126:384–9.

11.

Beaver

Matheny

Roberts

. Predictors of weight loss during radiation therapy. Otolaryngol Head Neck Surg 2001;125:645–8.

12.

Hirsch

Caldarelli

Hutchison

Jr . Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer. Laryngoscope 1991;101:583–6.

13.

Koch

Lee

Eisele

. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:974–80.

14.

Murry

Madasu

Martin

. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 1998;20:31–7.

15.

Newman

Vieira

Schwiezer

. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998; 124:589–92.

16.

Eisbruch

Lyden

Bradford

. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;53:22–8.

17.

Staton

Robbins

Newman

. Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg 2002;127:43–7.

18.

Graner

Foote

Kasperbauer

. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 2003;113:573–9.

19.

Skoner

Andersen

Cohen

. Swallowing function and tracheotomy dependence after combined-modality treatment including free tissue transfer for advanced-stage oropharyngeal cancer. Laryngoscope 2003;113:1294–8.

20.

Robbins

Barriers to winning the battle with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;53:4–5.

21.

List

Mumby

Haraf

. Performance and quality of life outcome in patients completing chemoradiotherapy for head and neck cancer. Qual Life Res 1997;6:274–84.

22.

Buntzel

Kuttner

Frohlich

. Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 1998;9:505–9.

23.

Mekhail

Adelstein

Rybicki

. Enteral nutrition during treatment of head and neck cancer: Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 2001;91:1785–90.